160 related articles for article (PubMed ID: 24557581)
21. Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma.
Lee JR; Roh JL; Lee SM; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
Head Neck; 2018 Nov; 40(11):2340-2346. PubMed ID: 30303590
[TBL] [Abstract][Full Text] [Related]
22. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
23. Does buccal cancer have worse prognosis than other oral cavity cancers?
Camilon PR; Stokes WA; Fuller CW; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1386-91. PubMed ID: 24807684
[TBL] [Abstract][Full Text] [Related]
24. High nuclear protein kinase Cθ expression may correlate with disease recurrence and poor survival in oral squamous cell carcinoma.
Chu PY; Hsu NC; Tai HC; Yeh CM; Lin SH; Hou MF; Yeh KT
Hum Pathol; 2012 Feb; 43(2):276-81. PubMed ID: 21840039
[TBL] [Abstract][Full Text] [Related]
25. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
[TBL] [Abstract][Full Text] [Related]
26. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma.
Chen S; Wang Q; Wang L; Chen H; Gao X; Gong D; Ma J; Kubra S; Yao X; Li X; Li L; Zhai W; Zheng J
Cell Death Dis; 2018 May; 9(6):627. PubMed ID: 29795381
[TBL] [Abstract][Full Text] [Related]
27. PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study.
Yu WN; Lin HF; Lee YI; Shia WC; Sung WW; Yeh CM; Lin YM
Anticancer Res; 2021 Apr; 41(4):2177-2182. PubMed ID: 33813430
[TBL] [Abstract][Full Text] [Related]
28. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
29. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
[TBL] [Abstract][Full Text] [Related]
30. High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma.
Tang JY; Hsi E; Huang YC; Hsu NC; Chu PY; Chai CY
Hum Pathol; 2013 Nov; 44(11):2558-62. PubMed ID: 24055091
[TBL] [Abstract][Full Text] [Related]
31. Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.
Luksic I; Suton P
Head Neck; 2017 Apr; 39(4):694-701. PubMed ID: 28006084
[TBL] [Abstract][Full Text] [Related]
32. The relevance of surgical margins in clinically early oral squamous cell carcinoma.
Bajwa MS; Houghton D; Java K; Triantafyllou A; Khattak O; Bekiroglu F; Schache AG; Brown JS; McCaul JA; Rogers SN; Lowe D; McMahon J; Shaw RJ
Oral Oncol; 2020 Nov; 110():104913. PubMed ID: 32711167
[TBL] [Abstract][Full Text] [Related]
33. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
34. Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion.
Shimizu S; Miyazaki A; Sonoda T; Koike K; Ogi K; Kobayashi JI; Kaneko T; Igarashi T; Ueda M; Dehari H; Miyakawa A; Hasegawa T; Hiratsuka H
PLoS One; 2018; 13(4):e0195451. PubMed ID: 29672550
[TBL] [Abstract][Full Text] [Related]
35. Pain may predict poor prognosis in patients with oral squamous cell carcinoma.
Sato J; Yamazaki Y; Satoh A; Onodera-Kyan M; Abe T; Satoh T; Notani K; Kitagawa Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):587-92. PubMed ID: 21497734
[TBL] [Abstract][Full Text] [Related]
36. Influence of tumor volume on survival in patients with oral squamous cell carcinoma.
Mücke T; Mitchell DA; Ritschl LM; Tannapfel A; Wolff KD; Kesting MR; Loeffelbein DJ; Kanatas A
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1007-11. PubMed ID: 25423880
[TBL] [Abstract][Full Text] [Related]
37. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
38. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of serum liver enzymes in oral and oropharynx squamous cell carcinomas.
Zhu Z; Zhou J; Xiong X; Liu D; Zheng Y; Ding X; Du Y; Gu N; Wu Y; Song X
J Oral Pathol Med; 2019 Jan; 48(1):36-42. PubMed ID: 30447114
[TBL] [Abstract][Full Text] [Related]
40. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
